US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi Genomics & Precision Medicine ETF

35.04

-0.8022-2.24%

Volume:2K

Turnover:68.66K

Market Cap:1.58M

PE:- -

High:35.04

Open:35.04

Low:35.04

Close:35.84

52wk High:35.84

52wk Low:23.88

Shares:45.00K

Float Shares:45.00K

Volume Ratio:6.95

T/O Rate:4.36%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances

Sector Update: Healthcare

MT Newswires Live

Alnylam to present new clinical data on ATTR, hypertension at ESC Congress

Guardant Health Loses $245.2 Million Patent Infringement Case

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/GNMX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNMX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","market":"US","secType":"STK","nameCN":"Corgi Genomics & Precision Medicine ETF","latestPrice":35.035,"timestamp":1787581139280,"preClose":35.8372,"halted":0,"volume":1960,"delay":0,"changeRate":-0.022384561293851253,"floatShares":45000,"shares":45000,"eps":0,"marketStatus":"Trading","change":-0.8022,"latestTime":"08-24 10:31:30 EDT","open":35.035,"high":35.035,"low":35.035,"amount":68660.0152,"amplitude":0,"askPrice":35.32,"askSize":1100,"bidPrice":35.09,"bidSize":1100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1302235200000,"exchange":"CBOE","adjPreClose":35.8372,"nav":35.12,"aum":1580400,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":35.82,"preClose":35.8372,"latestTime":"16:10 EDT","volume":6,"amount":215.0232,"timestamp":1787343004158,"change":-0.0172,"changeRate":-0.00048,"amplitude":0},"volumeRatio":6.945934,"impliedVol":0.1803,"impliedVolPercentile":0.3582},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNMX\",,,,,undefined,":{"symbol":"GNMX","floatShares":45000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":6.945934,"shares":45000,"dividePrice":0,"high":35.035,"amplitude":0,"preClose":35.8372,"low":35.035,"week52Low":23.88,"pbRate":"--","week52High":35.8439,"institutionHeld":0,"latestPrice":35.035,"eps":0,"divideRate":0,"volume":1960,"delay":0,"ttmEps":0,"open":35.035,"prevYearClose":25.56,"prevWeekClose":35.8372,"prevMonthClose":29.7248,"prevQuarterClose":31.0879,"fiveDayClose":32.3271,"twentyDayClose":29.7525,"sixtyDayClose":26.8115},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNMX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNMX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNMX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNMX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661271017","title":"Renalytix Discloses Director’s Link to Trellus Administration as KidneyIntelX Rollout Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271017","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271017?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:42","pubTimestamp":1787578963,"startTime":"0","endTime":"0","summary":"Renalytix ( ($GB:RENX) ) has issued an update. Renalytix plc, a London- and New York-based precision medicine diagnostics group, specializes in art...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/renalytix-discloses-directors-link-to-trellus-administration-as-kidneyintelx-rollout-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GNMX","WDNA","LFSC","TMAT","HTEC","FDIF","BK4585","IDNA","GNOM","XT","HELX","BMED","PBE","SYNB","BK4588","IBB","MEDX","JDOC","GDOC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279439","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279439","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279439?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:58","pubTimestamp":1787576324,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF  0.4% higher and the iShares Biotechnology ETF  down 0.2%,Guardant Health  lost a $245.2 million patent infringement lawsuit filed by TwinStrand Biosciences and the University of Washington, TwinStrand said. Guardant Health stock was down more than 1% premarket.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HELX","BK4588","BK4535","IE00B3QW5Z07.USD","GH","XBI","BK4585","BK4135","GNMX","LU0109394709.USD","LU1894683348.USD","BK4196","LU0320765992.SGD","LU1894683264.USD","PTH","STT","BK4137","BK4551","EKG","LFSC","GDOC","IE0034235188.USD","BK4581","LU0128526141.USD","IBB","XLV","GNOM","LABU","LU0889565916.HKD","IE00BGHQF748.EUR","LU1883839398.USD","FFOX","LU0029874061.USD","FDN","LU0061475181.USD","HCSG","BK4550","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661279552","title":"Alnylam to present new clinical data on ATTR, hypertension at ESC Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2661279552","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661279552?lang=en_us&edition=fundamental","pubTime":"2026-08-24 20:40","pubTimestamp":1787575225,"startTime":"0","endTime":"0","summary":"Alnylam (ALNY) Pharmaceuticals announced that it will present new clinical and real-world data across its transthyretin-mediated amyloidosis, ATTR,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alnylam-to-present-new-clinical-data-on-attr-hypertension-at-esc-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alnylam-to-present-new-clinical-data-on-attr-hypertension-at-esc-congress-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU0114720955.EUR","BK4588","LU0882574055.USD","ATTR","BK4548","GNMX","ALNY","BK4585","LU0109394709.USD","PBE","LU0889565916.HKD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661752702","title":"Guardant Health Loses $245.2 Million Patent Infringement Case","url":"https://stock-news.laohu8.com/highlight/detail?id=2661752702","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661752702?lang=en_us&edition=fundamental","pubTime":"2026-08-24 19:51","pubTimestamp":1787572313,"startTime":"0","endTime":"0","summary":"Guardant Health  lost a $245.2 million patent infringement lawsuit filed by TwinStrand Biosciences and the University of Washington, TwinStrand said Monday.The final judgment, issued Friday, maintains a November 2023 jury verdict finding that Guardant Health willfully infringed two patents underlying TwinStrand's Duplex Sequencing technology in 11 royalty-bearing products and services, and awards TwinStrand and the University of Washington damages, accrued royalties and interest for infringement through May 31, 2026, the company said.The court ordered Guardant Health to pay a 6% royalty on sales of the covered products and services from June 1, 2026 until the expiration of the patents on March 15, 2033, the company said.Guardant is also required to provide quarterly accounting of US sales of the covered products and services, TwinStrand said.Guardant did not iimmediately reply to MT Newswires' request for comment.Shares of Guardant were down 1.6% in recent premarket trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HELX","BK4585","GNOM","GH","BK4551","GNMX","LFSC","BK4196","EKG","LU0109394709.USD","LU0889565916.HKD","BK4588","GDOC","PTH","LU0320765992.SGD","BK4535","FFOX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GNMX\",params:#limit:6,delay:false,,,undefined,":[]}}